Brawn Biotech Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
367,001.30
379,779.50
455,859.10
597,801.00
557,837.00
651,790
Cost of Goods Sold (COGS) incl. D&A
351,255.60
368,798.40
433,608.70
544,523.90
518,600.00
615,551
Gross Income
15,745.70
10,981.10
22,250.30
53,277.10
39,237.00
36,239
SG&A Expense
21,823.30
12,212.80
20,306.20
41,040.80
19,950.00
24,950
EBIT
6,346.40
1,242.10
1,878.00
12,143.40
19,287.00
11,289
Unusual Expense
7,762.70
-
-
-
-
-
Non Operating Income/Expense
16,901.10
6,332.70
11,563.00
5,611.60
897.00
7,378
Interest Expense
515.50
307.10
391.40
258.00
573.00
614
Pretax Income
2,276.50
4,783.50
13,049.60
17,557.40
19,610.00
18,054
Income Tax
829.70
1,940.50
3,552.20
3,633.10
6,794.00
4,724
Consolidated Net Income
1,183.10
2,980.90
9,497.40
13,924.30
12,816.00
13,329
Net Income
1,183.10
2,980.90
9,497.40
13,924.30
12,816.00
13,329
Net Income After Extraordinaries
1,183.10
2,980.90
9,497.40
13,924.30
12,816.00
13,329
Net Income Available to Common
1,183.10
2,980.90
9,497.40
13,924.30
12,816.00
13,329
EPS (Basic)
0.39
0.99
3.17
4.64
4.18
4.63
Basic Shares Outstanding
3,000.30
3,000.30
3,000.30
3,000.30
-
-
EPS (Diluted)
0.39
0.99
3.17
4.64
-
-
Diluted Shares Outstanding
3,000.30
3,000.30
3,000.30
3,000.30
-
-
EBITDA
6,199.20
980.30
2,210.40
12,454.60
19,603.00
11,609
Other Operating Expense
268.80
10.40
66.20
92.90
-
-
Non-Operating Interest Income
-
-
-
60.40
-
-
Other After Tax Income (Expense)
263.70
137.90
-
-
-
-

About Brawn Biotech

View Profile
Address
Near Hero Honda Factory Gurgaon
Gurgon Haryana 122001
India
Employees -
Website http://www.brawnbiotech.com
Updated 07/08/2019
Brawn Biotech Ltd. engages in the manufacturing, contracting and supplying pharmaceutical and healthcare products. Its products include antibacterials, cardiovasculars, antidiabetics, analgesics, gastrointestinals, antifungals, skin care, antipsychotics, antiasthmatics, antacids, antimalarials and nutritionals. The company was founded in 1985 and is headquartered in New Delhi, India.